Antithrombotic and profibrinolytic activities of phloroglucinol

Food and Chemical Toxicology

Volumn 49, Issue 7, 2011, Pages 1572-1577

  Bae, Jong Sup ^a  

^a Kyungpook National University   (South Korea)

Author keywords

Coagulation; Endothelium; Fibrinolysis; Phloroglucinol; TNF

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5A; EMODIN; HEPARIN; I KAPPA B; MITOGEN ACTIVATED PROTEIN KINASE; PHLOROGLUCINOL; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA;

ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; FIBRINOLYSIS; HUMAN; HUMAN CELL; PARTIAL THROMBOPLASTIN TIME; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTHROMBIN TIME; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTITHROMBINS; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FACTOR XA; FIBRINOLYTIC AGENTS; GENE EXPRESSION REGULATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PARTIAL THROMBOPLASTIN TIME; PHAEOPHYTA; PHLOROGLUCINOL; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN TIME; SIGNAL TRANSDUCTION; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR-ALPHA;

PHAEOPHYCEAE;

EID: 79957660443     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.04.003     Document Type: Article

References (36)

1. Ahn G., Hwang I., Park E., Kim J., Jeon Y.J., Lee J., Park J.W., Jee Y. Immunomodulatory effects of an enzymatic extract from Ecklonia cava on murine splenocytes. Mar. Biotechnol. (NY) 2008, 10:278-289.
2. Ahn M.J., Yoon K.D., Min S.Y., Lee J.S., Kim J.H., Kim T.G., Kim S.H., Kim N.G., Huh H., Kim J. Inhibition of HIV-1 reverse transcriptase and protease by phlorotannins from the brown alga Ecklonia cava. Biol. Pharm. Bull. 2004, 27:544-547.
3. Athukorala Y., Kim K.N., Jeon Y.J. Antiproliferative and antioxidant properties of an enzymatic hydrolysate from brown alga, Ecklonia cava. Food Chem. Toxicol. 2006, 44:1065-1074.
4. Bae J.S., Rezaie A.R. Thrombin inhibits nuclear factor κB and RhoA pathways in cytokine-stimulated vascular endothelial cells when EPCR is occupied by protein C. Thromb. Haemost. 2009, 101:513-520.
5. Bae J.S., Rezaie A.R. Thrombin and activated protein C inhibit the expression of secretory group IIA phospholipase A(2) in the TNF-alpha-activated endothelial cells by EPCR and PAR-1 dependent mechanisms. Thromb. Res. 2010, 125:e9-e15.
6. Berk B.C., Abe J.I., Min W., Surapisitchat J., Yan C. Endothelial atheroprotective and anti-inflammatory mechanisms. Ann. NY Acad. Sci. 2001, 947:93-109. (discussion 109-111).
7. Della Valle P., Crippa L., Garlando A.M., Pattarini E., Safa O., Vigano D'Angelo S., D'Angelo A. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome. Haematologica 1999, 84:1065-1074.
8. Esmon C.T. Role of coagulation inhibitors in inflammation. Thromb. Haemost. 2001, 86:51-56.
9. Esmon C.T., Fukudome K., Mather T., Bode W., Regan L.M., Stearns-Kurosawa D.J., Kurosawa S. Inflammation, sepsis, and coagulation. Haematologica 1999, 84:254-259.
10. Fukuyama Y., Kodama M., Miura I., Kinzyo Z., Mori H., Nakayama Y., Takahashi M. Anti-plasmin inhibitor. VI. Structure of phlorofucofuroeckol A, a novel phlorotannin with both dibenzo-1,4-dioxin and dibenzofuran elements, from Ecklonia kurome Okamura. Chem. Pharm. Bull. (Tokyo) 1990, 38:133-135.
11. Furie B., Furie B.C. Thrombus formation in vivo. J. Clin. Invest. 2005, 115:3355-3362.
12. Ghosh S., Ezban M., Persson E., Pendurthi U., Hedner U., Rao L.V. Activity and regulation of factor VIIa analogs with increased potency at the endothelial cell surface. J. Thromb. Haemost. 2007, 5:336-346.
13. Glombitza K.W., Hauperich S., Keusgen M. Phlorotannins from the brown algae Cystophora torulosa and Sargassum spinuligerum. Nat. Toxins 1997, 5:58-63.
14. Hamaguchi E., Takamura T., Shimizu A., Nagai Y. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-κB-dependent pathways in cultured human umbilical vein endothelial cells. J. Pharmacol. Exp. Ther. 2003, 307:987-994.
15. Huber K. Plasminogen activator inhibitor type-1 (part one): basic mechanisms, regulation, and role for thromboembolic disease. J. Thromb. Thrombolysis 2001, 11:183-193.
16. Kang H.S., Chung H.Y., Jung J.H., Son B.W., Choi J.S. A new phlorotannin from the brown alga Ecklonia stolonifera. Chem. Pharm. Bull. (Tokyo) 2003, 51:1012-1014.
17. Kang H.S., Chung H.Y., Kim J.Y., Son B.W., Jung H.A., Choi J.S. Inhibitory phlorotannins from the edible brown alga Ecklonia stolonifera on total reactive oxygen species (ROS) generation. Arch. Pharm. Res. 2004, 27:194-198.
18. Kim M.M., Kim S.K. Effect of phloroglucinol on oxidative stress and inflammation. Food Chem. Toxicol. 2010, 48:2925-2933.
19. Kim M.M., Ta Q.V., Mendis E., Rajapakse N., Jung W.K., Byun H.G., Jeon Y.J., Kim S.K. Phlorotannins in Ecklonia cava extract inhibit matrix metalloproteinase activity. Life Sci. 2006, 79:1436-1443.
20. Kim T.H., Bae J.S. Ecklonia cava extracts inhibit lipopolysaccharide induced inflammatory responses in human endothelial cells. Food Chem. Toxicol. 2010, 48:1682-1687.
21. Kong C.S., Kim J.A., Yoon N.Y., Kim S.K. Induction of apoptosis by phloroglucinol derivative from Ecklonia cava in MCF-7 human breast cancer cells. Food Chem. Toxicol. 2009, 47:1653-1658.
22. Li Y., Qian Z.J., Ryu B., Lee S.H., Kim M.M., Kim S.K. Chemical components and its antioxidant properties in vitro: an edible marine brown alga, Ecklonia cava. Bioorg. Med. Chem. 2009, 17:1963-1973.
23. Lopez S., Peiretti F., Bonardo B., Juhan-Vague I., Nalbone G. Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells. Atherosclerosis 2000, 152:359-366.
24. Philip-Joet F., Alessi M.C., Philip-Joet C., Aillaud M., Barriere J.R., Arnaud A., Juhan-Vague I. Fibrinolytic and inflammatory processes in pleural effusions. Eur. Respir. J. 1995, 8:1352-1356.
25. Popa C., Netea M.G., van Riel P.L., van der Meer J.W., Stalenhoef A.F. The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J. Lipid Res. 2007, 48:751-762.
26. Quinn C., Hill J., Hassouna H. A guide for diagnosis of patients with arterial and venous thrombosis. Clin. Lab. Sci. 2000, 13:229-238.
27. Rao L.V., Rapaport S.I., Lorenzi M. Enhancement by human umbilical vein endothelial cells of factor Xa-catalyzed activation of factor VII. Blood 1988, 71:791-796.
28. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
29. Schleef R.R., Bevilacqua M.P., Sawdey M., Gimbrone M.A., Loskutoff D.J. Cytokine activation of vascular endothelium. Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J. Biol. Chem. 1988, 263:5797-5803.
30. Schouten M., Wiersinga W.J., Levi M., van der Poll T. Inflammation, endothelium, and coagulation in sepsis. J. Leukoc. Biol. 2008, 83:536-545.
31. Sugo T., Nakamikawa C., Tanabe S., Matsuda M. Activation of prothrombin by factor Xa bound to the membrane surface of human umbilical vein endothelial cells: its catalytic efficiency is similar to that of prothrombinase complex on platelets. J. Biochem. 1995, 117:244-250.
32. Surapisitchat J., Hoefen R.J., Pi X., Yoshizumi M., Yan C., Berk B.C. Fluid shear stress inhibits TNF-alpha activation of JNK but not ERK1/2 or p38 in human umbilical vein endothelial cells: inhibitory crosstalk among MAPK family members. Proc. Natl. Acad. Sci. USA 2001, 98:6476-6481.
33. van den Berg E.A., Sprengers E.D., Jaye M., Burgess W., Maciag T., van Hinsbergh V.W. Regulation of plasminogen activator inhibitor-1 mRNA in human endothelial cells. Thromb. Haemost. 1988, 60:63-67.
34. van Hinsbergh V.W., Kooistra T., van den Berg E.A., Princen H.M., Fiers W., Emeis J.J. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood 1988, 72:1467-1473.
35. Wiman B. Plasminogen activator inhibitor 1 (PAI-1) in plasma: its role in thrombotic disease. Thromb. Haemost. 1995, 74:71-76.
36. Yoshizumi M., Fujita Y., Izawa Y., Suzaki Y., Kyaw M., Ali N., Tsuchiya K., Kagami S., Yano S., Sone S., Tamaki T. Ebselen inhibits tumor necrosis factor-alpha-induced c-Jun N-terminal kinase activation and adhesion molecule expression in endothelial cells. Exp. Cell Res. 2004, 292:1-10.